在良性肌肉切除术或子宫切除术中意外恶性的发生率和预测因素
Fatema Y Sabt1, Hasan M Isa2,3, Zahra A Khudair1
1Department of Obstetrics and Gynecology, Salmaniya Medical Complex, Manama, BHR.
Cureus
|September 16, 2024
概括
意外的恶性瘤 (UM) 在1.3%的患者中被发现,这些患者因被认为是良性的疾病而接受了子宫切除术或肌切除术. 瘤是最常见的UM类型,没有确定任何预测因素.
科学领域:
- 妇科瘤学 妇科瘤学
- 手术病理学手术病理学
- 流行病学 流行病学
背景情况:
- 妇科癌症的手术前检测对于患者的管理至关重要.
- 意想不到的恶性瘤 (UM) 可以发生在手术中,假定是良性的条件.
研究的目的:
- 为了确定UM的发病率在患者进行切除术或肌切除术为良性征兆.
- 为了确定UM的潜在预测因素.
主要方法:
- 对379名经过子宫切除术或肌切除术的患者 (2016-2020年) 的回顾性分析.
- 对UM和良性病理之间的特征进行比较.
- 二元逻辑回归用于识别UM的预测因素.
主要成果:
- 总体上,UM的发生率为1.3% (5/379).
- 肉 Sarcomas (leiomyosarcoma,子宫内膜层肉瘤) 是最常见的UM类型 (3/5).
- 在UM和良性病理之间没有发现显著的特征差异;没有独立变量预测UM.
结论:
- UM的发病率很低,但可能发生在年轻的患者中 (年仅34岁).
- 瘤是最常见的意外恶性瘤.
- 当前的独立变量不能在这个人群中可靠地预测UM.
更多相关视频
03:01Author Spotlight: A Reproductive Hysteroscopy Approach for Complete Endometrial Polyp Removal and Enhanced Endometrial Receptivity
Published on: August 2, 2024
604
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
226
相关概念视频
Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
